Facilitated By

San Antonio Medical Foundation

News

  • Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study ...

    ... breaking presentation at the 2025 San Antonio Breast Cancer Symposium (SABCS) taking place December 9-12.

  • Cleveland Clinic Presents Final Results of Phase 1 Clinical Trial of Preventive Breast ...

    The findings, which will inform the subsequent Phase 2 study, are being presented at the San Antonio Breast Cancer Symposium. “Triple-negative ...

  • Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study ...

    Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium.

  • Kazia Therapeutics stock price target raised to $18 from $13 at HC Wainwright

    ... San Antonio Breast Cancer Symposium on December 10. The key finding highlighted in the presentation was a 76% tumor volume shrinkage in the first ...

  • Keep Texas Beautiful South Texas Regional Training | TPR - Texas Public Radio

    Keep Texas Beautiful is excited to announce an upcoming, in-person regional training in San Antonio ... Bioscience-Medicine · Border & Immigration ...